Tag: Decline

Categories
World News

The Dow is now up practically 600 factors as shares snap again from Monday’s decline

The Dow is now up nearly 600 points as stocks snap back from Monday's decline

Key averages rebounded on Tuesday as investors stepped in to buy the decline from the worst day on the Dow Jones Industrial in eight months.

The comeback rally picked up steadily during the session as a rebound in government bond yields allayed some concerns that a Covid resurgence would slow economic recovery.

At the last count, the Dow Jones Industrial Average rose 580 points, or 1.7%, after falling 725 points on Monday. It was the Dow’s biggest jump in more than a month. The S&P 500 was up 1.5% and the Nasdaq Composite was up 1.4%. The small cap benchmark Russell 2000 index rose 2.8%.

Many of the stocks, which were hardest hit on Monday due to concerns about the Delta variant of Covid-19, rebounded on Tuesday. American Airlines and Delta Air Lines gained 3% and 4% respectively. Royal Caribbean was up 3% after falling 4% on Monday.

Bank stocks are also rebounding as investors continue to monitor bond yields under pressure. JPMorgan, Citigroup and Bank of America are all up more than 2%.

Energy and industrials – two of the hardest hit groups on Monday – also shot back. Exxon Mobil and Chevron were both up 1%. General Electric and Honeywell gained more than 3%.

Wall Street suffered a sharp sell-off on Monday as investors feared the fast-spreading delta coronavirus variant could hamper economic recovery. The blue-chip Dow plunged 2.1%, its worst day since October 28th last year. The S&P 500 was down 1.6% and the Nasdaq Composite was down about 1.1%.

“We remain constructive on equities and see recent growth and slowdown fears premature and exaggerated,” Dubravko Lakos-Bujas, head of US equity strategy at JPMorgan, wrote in a statement on Tuesday. The strategist raised his price target for the S&P 500 from 4,400 to 4,600 at the end of the year, which corresponds to a gain of 8% compared to the closing price on Monday.

Traders continue to watch the 10-year government bond yield, which appears to be driving movement in the equity markets. It fell to a 5-month low on Monday, adding to concerns about the slowing global economy and helping to push stocks down, and fell briefly to 1.128% early Tuesday. It was above 1.78% in March and its decline amid the recovering economy has puzzled and worried investors.

With the rebound on Tuesday, the S&P 500 is only 2% below its record hit last week. During Monday’s losses, the stock benchmark traded below its 50-day moving average at times. However, the index closed above this important technical level on Monday, an optimistic sign for traders that anticipated Tuesday’s rally.

CNBC’s Jim Cramer said Monday’s sell-off drove out some of the speculators who are taking too much risk in stocks this year and it would end soon.

“Once the speculators are blown out … and stocks that have already fallen sharply start rallying, we can find tradable bottom,” said Cramer. “We’re close, but the speculators aren’t completely crushed yet.”

Bitcoin fell below the $ 30,000 mark overnight, triggering sales on cryptocurrencies and another sign that speculation may be coming out of the markets.

In the USA, new Covid cases are recovering, as the delta variant is spreading mainly among the unvaccinated. According to CDC data, there are an average of about 26,000 daily cases in the US for the past seven days, more than double the average from a month ago.

“Many of the cyclical companies are selling out of fears that Covid will stop the recovery,” said Chris Zaccarelli, CIO at Independent Advisor Alliance. “We do not believe this is the case and are ready to let the sell-off take its course and buy the slump believing that the economy will fully recover and return to its previous growth trajectory, which is what most cyclical companies do in the country brings. ” the airline, travel and leisure industries along with it. “

Categories
Health

C.D.C. Requires Up to date Childhood Vaccinations After Decline Final 12 months

C.D.C. Calls for Updated Childhood Vaccinations After Decline Last Year

Pediatricians urge U.S. parents to get their children given routine vaccinations after vaccinations for diseases such as measles declined last year as the pandemic imposed restrictions, including the arrangement of homes.

New data from 10 jurisdictions that closely monitor vaccinations confirms that the number of vaccine doses administered fell between March and May last year, particularly in older children, the Centers for Disease Control and Prevention reported Thursday.

Although vaccinations recovered between June 2020 and September 2020 and were approaching pre-pandemic levels, the increase was insufficient to offset the earlier decline, the study found.

Vaccination is required to attend most schools, camps and daycare, but the CDC study authors warned that the delay could nonetheless pose “a serious public health threat that would lead to vaccine-preventable disease outbreaks.”

They expressed concern that the move to distance learning during the pandemic may have hampered enforcement of vaccination regulations, noting that even a temporary drop in vaccination can affect herd immunity.

A measles outbreak occurred in Rockland County, NY and surrounding counties in 2018-2019 after the measles vaccination rate in schools in the area dropped to 77 percent, among the 93 to 95 percent required to maintain herd immunity are. “Pediatric outbreaks of vaccine-preventable diseases can undo efforts to reopen schools this fall,” the researchers added.

Parents should plan ahead now and make appointments so their children can be protected, said Dr. Yvonne Maldonado, Chair of the Infectious Diseases Committee at the American Academy of Pediatrics.

“We should start thinking about it,” said Dr. Maldonado in a telephone interview. “People forget. We have whooping cough outbreaks regularly every four or five years and are just waiting to see another. “

“We’ll likely see more infections because the kids will get back together and there will be less masking and social distancing,” she added.

The CDC analyzed data from nine states and New York City. In eight of the jurisdictions, a stay at home order was issued last spring.

The number of doses of diphtheria, tetanus and pertussis vaccines (DTaP) administered decreased by 15.7 percent in children under 2 years of age and in children aged from in the spring of last year compared to the same period in 2018 and 2019 2 to 6 years back by 60 percent.

The vaccine doses against measles, mumps and rubella (MMR) fell by 22.4 percent in 1-year-olds and by 63 percent in 2 to 8-year-olds.

HPV vaccine administration decreased more than 63 percent in adolescents aged 9-17 years compared to the same period in 2018 and 2019; and doses of Tdap (tetanus, diphtheria, and whooping cough) decreased by over 60 percent.

Categories
Health

Crimson Knots in Steepest Decline in Years, Threatening the Species’ Survival

Red Knots in Steepest Decline in Years, Threatening the Species’ Survival

The number of red knots visiting the beaches of Delaware Bay during this spring’s north migration unexpectedly dropped to its lowest level since counts began nearly 40 years ago, adding to concerns about the survival of the shorebird and a sharp setback for a quarter of a century his efforts meant to save him.

Conservationists found fewer than 7,000 of the bird’s rufa subspecies in extensive land, air and water counts on the New Jersey and Delaware side in May. The number is about a third of that found in 2020; less than a quarter of the level for the past two years; and the lowest since the early 1980s when the population was around 90,000.

The numbers were already well below the level that would ensure the bird’s survival. A previous decline had been halted by years of conservation efforts, including a New Jersey ban on harvesting horseshoe crabs, the eggs of which provide essential nourishment for birds on their long-distance migrations.

The recent decline is making the Rufa subspecies – which has been endangered at the federal level since 2014 – even more susceptible to external shocks such as bad weather in their Arctic breeding areas and bringing them closer to extinction, say naturalists.

“I think we need to think about the red knot as a dying species, and we really need immediate action,” said Joanna Burger, a biologist at Rutgers University. Since the early 1980s, she has been studying the knot and other deciduous shorebirds such as ruddy turnstone and semi-palmate sandpipers in Delaware Bay.

She called for an immediate ban on the fishing of horseshoe crabs as bait, an industry that still operates in Delaware, Maryland and Virginia and is subject to quotas from the Atlantic States Marine Fisheries Commission. Although regulators do not allow female crabs to be harvested, naturalists say the rule will not be strictly enforced, resulting in the loss of some of the egg-laying animals and a consequent reduction in the birds’ food supply.

The recent decline also fueled calls by naturalists to urge the pharmaceutical industry to stop using LAL, an extract from the blood of crabs used to detect bacteria in vaccines, drugs and medical devices. A synthetic alternative, rFC, is available and used by at least one pharmaceutical company, but the industry as a whole has been slow to embrace the new technique, resulting in continued demand for horseshoe crabs in the bay.

Although the crabs are returned to the sea after bleeding, conservationists believe that up to a third will die or be unable to reproduce. Ironically, there were plenty of crab eggs to eat on the beaches of the bay this year, but a long-term decline in egg availability has severely dented the bird population and thinned any cushion that would allow the species to survive natural hazards.

Larry Niles, an independent wildlife biologist who has trapped, monitored, and counted shorebirds on New Jersey’s bay beaches for the past 25 years, said he expected this year’s red knots to decline as there was evidence of a bad breeding season in season 2020 but shocked at the size of the decline.

He said it was likely due to low sea temperatures in the mid-Atlantic during the 2020 migration. The cold water delayed spawning of the horseshoe crabs until early June, when the birds had already left Delaware Bay to complete their migration.

Many of the birds, weighing just 4.7 ounces when fully grown, are emaciated after flying from Tierra del Fuego in southern Argentina on one of the longest bird migrations. Some fly non-stop for seven days before reaching Delaware Bay, where they usually stay for about two weeks to rest and gain weight.

But last year many could not find food in the bay and continued north to reach their breeding grounds. Dr. Niles estimates that about 40 percent of migrants died in the last year before reaching the Arctic simply because they ran out of energy.

In that year he also blamed the predation by peregrine falcons, whose growing coastal population was supported by the construction of nesting platforms in New Jersey. They often hunt over the beaches of the bay, making it harder for flocks of shorebirds to feed and gain weight.

The best hope for the species’ survival lies in a complete ban on harvesting female horseshoe crabs until the crab population has recovered, said Dr. Niles.

“Rufa nodes, especially red long-haul nodes, could be lost,” he said in a message to supporters. “We can’t stop bad winds or cold water, but we can increase the horseshoe crab population so that birds that arrive in most of these conditions will find an abundance of horseshoe crab eggs.”

Categories
Business

Don’t overreact to a inventory’s post-earnings decline

Do not overreact to a stock's post-earnings decline

The latest round of corporate earnings reports demonstrated the importance of staying true to comprehensive stock analysis without reacting to initial price action, CNBC’s Jim Cramer said Friday.

“You can’t assume that something is wrong just because a stock sells in response to profits, but that’s exactly what so many traders do,” said the Mad Money host. “The truth is that winning season is a confusing time and the initial market reaction is often wrong.”

DraftKings, which released results on Friday, and Penn National Gaming, which reported Thursday, are the two most recent examples, according to Cramer.

“Both companies reported significantly better than expected sales. Both companies are well on their way to dominate one of the strongest and fastest growing areas in this entire economy, which is gambling,” said Cramer.

However, Penn National stocks fell sharply on Thursday, as did DraftKings on Friday.

Rather than focusing on the initial stock movement, Cramer said he had stuck to his routine of reading conference call logs and was “convinced the sellers are actually not on the ground,” while revealing he had previously did some work for DraftKings.

Penn National made up some of its losses from the previous session on Friday, up more than 3%. It’s up 0.3% since the start of the year, while DraftKings is up 4% so far in 2021.

Health insurance company Centene and steel maker Nucor are also reiterating the need for investors to be prudent when evaluating earnings reports, Cramer said.

After interviewing Michael Neidorff, CEO of Centene, following the company’s results last week and reviewing the financials, Cramer said, “I independently concluded and told you that Centene should be bought.”

After Centene shook off selling pressure, it bounced back, Cramer said. “Boom, the stock is now up 18% since it settled.”

“The next time you get shaken about the action, remember examples like Centene and examples like Nucor. Trust your instincts, people, not the direction of the stock,” Cramer said. “Most of the time, when you do your homework, your judgment should be better than the market’s.”

Categories
Health

Gottlieb says circumstances will decline, vaccinations monumental achievement

Gottlieb says cases will decline, vaccinations monumental achievement

A vaccination center displays signs and age groups for Pfizer and Moderna vaccines as California reveals eligibility to vaccinate all residents 16 and older during the coronavirus disease (COVID-19) outbreak in Chula Vista, California, United States on April 15 2021.

Mike Blake | Reuters

Former Food and Drug Administration Commissioner Scott Gottleib said Sunday that a steep decline in new Covid-19 cases in the US is likely to continue and predicted a “relatively calm summer in terms of the spread of coronavirus” .

“Look, the situation in the US continues to improve, and I think the decline in cases will accelerate in the coming weeks,” Gottlieb said on CBS News’ Face the Nation.

The doctor credited the mass vaccination campaign launched under President Donald Trump and continued under President Joe Biden to help stem the spread of the disease.

“This was a monumental achievement – the introduction of this vaccine, the vaccination of so many Americans – and it will go on,” said Gottlieb. “We will keep working on it. The vaccination rate will slow down in the coming weeks. But we will continue to take in more people when we come into the summer.”

To date, more than 100 million Americans have been fully vaccinated against Covid-19, according to the Centers for Disease Control and Prevention, or nearly a third of the population. Approximately 146 million people, or 44% of the population, received at least one dose.

The rate of vaccine administration has declined slightly in the past few weeks after months of spike after receiving one for most of the people who were most likely to want a shot.

As more Americans got vaccines, cases of Covid-19 have fallen sharply. As of Saturday, the 7-day average of daily new cases fell to below 50,000, a decrease of 17% compared to the previous week. Hospital stays and deaths due to the disease are also decreasing.

To get a feel for what might be coming up for the US, Gottlieb said it might be helpful to check out heavily vaccinated San Francisco.

“About 71% of the people in San Francisco had at least one dose of the vaccine, 47% were fully vaccinated. They record about 20 cases a day. You have about 20 people hospitalized,” Gottlieb said.

“They have dramatically reduced Covid in this city and it is largely the result of vaccinations,” he added.

From a financial point of view, Gottlieb suggested that the profits from vaccination were “stalled” and “fairly sustainable”.

“We are entering warm months in which this will create a setback against the spread of the coronavirus, and we are securing these profits,” said Gottlieb.

Even if the health situation in the USA is on the verge of normal, it is deteriorating in other countries with fewer resources. In India, the new daily cases exceeded 400,000 on Saturday, a record.

Disclosure: Scott Gottlieb is a CNBC employee and a member of the boards of directors of Pfizer, genetic testing startup Tempus, health technology company Aetion Inc., and biotech company Illumina. He is also co-chair of the Healthy Sail Panel for Norwegian Cruise Line Holdings and Royal Caribbean.

Subscribe to CNBC Pro for the live TV stream, deep insights and analysis of how to invest over the next president’s term.

Categories
Health

Covid ‘risk stays current’ WHO says at the same time as Europe’s circumstances decline

Covid 'threat remains present' WHO says even as Europe's cases decline

A boy reacts next to the body of his father, who died of coronavirus disease (COVID-19), in a crematorium in New Delhi, India, on April 24, 2021.

Adnan Abidi | Reuters

LONDON – The threat to Europe from the coronavirus “remains,” the World Health Organization said Thursday, despite the recent drop in new cases, hospitalizations and deaths in the region.

“It has been 462 days since the first Covid-19 cases were reported. Based on the number of confirmed cases, 5.5% of the total European population had Covid-19, while 7% completed a full series of vaccinations,” he said WHO Regional Director for Europe, said Dr. Hans Kluge in a press conference on Thursday.

“But even if new cases, hospital stays and deaths decrease, the threat remains,” warned Kluge.

The virus still has the potential to wreak havoc, he added, noting that almost half of all reported infections in Europe since the pandemic began actually occurred in the first four months of this year.

However, as a sign of hope for the region, he added that “for the first time in two months, new cases fell significantly last week. Nevertheless, infection rates in the region remain extremely high.”

The comments are found amid a mixed picture of recovery around the world. As India grapples with a devastating surge in cases and a lack of medical care, other parts of the world are starting to reopen their economies.

In Europe, the UK is steadily lifting its lockdown and the introduction of vaccinations is progressing rapidly. To date, nearly 34 million adults in the country have received a first dose of a coronavirus vaccine, and over 13 million people have had two doses, government data shows.

In mainland Europe, according to the European Center for Disease Control and Prevention, over 133 million doses of Covid vaccines have been administered in 30 countries in the European Economic Area (EU plus Iceland, Liechtenstein and Norway).

The speed of vaccination programs varies widely across the EU, with some countries advancing faster than others.

WHO’s Kluge called on governments not to allow vaccination programs, public engagement for vaccines, or surveillance of the virus.

“Where vaccination rates are highest in high-risk groups, hospital admissions and death rates fall. Vaccines save lives, and they will change the course of this pandemic and ultimately help end it,” he said.

“We also need to be aware of the fact that vaccines alone will not end the pandemic.” Without informing and involving the communities, they remain exposed to the virus. Without monitoring, we cannot identify any new variants. And without tracing, governments may have to reintroduce restrictive measures. “

Categories
World News

Inventory futures are flat after S&P 500 and Nasdaq shut at information, Tesla shares decline

Stock futures are flat after S&P 500 and Nasdaq close at records, Tesla shares decline

Stock futures were unchanged on Tuesday as investors braced themselves for a large amount of technical gains.

Futures on the Dow Jones Industrial Average lost 30 points. The S&P 500 futures were flat. The Nasdaq 100 futures were also flat.

Tesla’s shares fell 3% in premarket trading even after the electric automaker posted a record $ 438 million profit. Tesla also significantly exceeded Wall Street’s earnings and earnings expectations, fueled by bitcoin sales and regulatory credit. Stocks have struggled this year, more than 18% from their record. Though the stock is still up 360% over the past 12 months.

The winning season for the first quarter starts in full swing on Tuesday. Major tech companies like Alphabet, Microsoft, and AMD are reporting after the bell.

So far, 84% of companies have had a positive earnings surprise, according to FactSet, as around a third of the S&P 500 have reported numbers. However, share movements were relatively subdued after the strong results as the market was at record levels with high valuations.

GameStop’s stock rose more than 8% in premarket trading after the video game retailer said it sold 3.5 million additional shares and raised $ 551 million to accelerate the company’s e-commerce transformation .

The S&P 500 rose to another record high on Monday, while the tech-heavy Nasdaq Composite rose 0.9% to hit its first new record high since February 12.

“Strong action suggests stocks may have even more upside,” said Jeff Buchbinder, equity strategist at LPL Financial. “Although valuations are elevated, they still seem reasonable given interest rates and inflation.”

The Federal Reserve starts its two-day session on Tuesday. The central bank is not expected to take action, but economists expect it to defend its policies to keep inflation running hot.

Apple and Facebook wins will follow after the bell on Wednesday.

Did you like this article?
For exclusive stock selection, investment ideas and CNBC Global Livestream
Sign up for CNBC Pro
Start your free trial now

Categories
Business

U.S. states face steep decline in J&J vaccine

U.S. states face steep decline in J&J vaccine

Vials labeled “COVID-19 Coronavirus Vaccine” and syringe can be seen in front of the displayed Johnson & Johnson logo in this illustration dated February 9, 2021.

Given Ruvic | Reuters

Johnson & Johnson is reducing shipments of its single-dose Covid-19 vaccine next week by 86% as it grapples with manufacturing issues at a large Baltimore facility.

The government allocated just 700,000 J&J shots to the states next week, up from 4.9 million the week before. This is based on data from the Centers for Disease Control and Prevention.

J&J is awaiting regulatory approval for a facility in Baltimore operated by Emergent BioSolutions Inc and is working with the U.S. Food and Drug Administration to obtain approval.

Workers at the Baltimore plant mixed the ingredients for the J&J and AstraZeneca vaccines a few weeks ago, resulting in around 15 million J&J doses being ruined. The Biden administration hired J&J to manufacture vaccines at the factory and stopped producing the AstraZeneca vaccine there.

Once approved, J&J could dispense up to eight million doses a week, White House Covid-19 coordinator Jeff Zients said during a news conference on Friday. And the company remains on track to deliver 100 million cans by the end of May.

Michigan Governor Gretchen Whitmer has urged the Biden administration to increase vaccines in her state, which is grappling with the country’s worst outbreak. Michigan is expected to receive 17,500 J&J cans next week, an 88% decrease from the previous week.

The government said it will continue to assign shots based on population and has no plans to increase doses to more affected states as it cannot predict where infections might rise next.

“There are tens of millions of people across the country in every state and county who have not yet been vaccinated,” Zients said Friday. “And the fair and just way to distribute the vaccine is based on the adult population by state, tribe and territory. That is how it was done, and we will continue to do it.”

“The virus is unpredictable. We don’t know where the next surge in cases might be,” he added.

New York Governor Andrew Cuomo said in a statement Friday that the state will only receive 34,900 doses, an 88% decrease from the previous week.

“As has been the case since our vaccination efforts began, the X-Factor is supply, supply, supply, and like any other state, our Johnson & Johnson dose allocation will be significantly lower next week,” said Cuomo.

In California, the J&J grant will decrease from 572,700 to 67,600. Florida from 313,200 to 37,000; and Texas from 392,100 to 46,300.

Some states have also temporarily suspended J&J vaccinations in certain facilities after people suffered side effects. The Georgia Department of Health stopped all recordings in one location after reactions occurred in eight people, and other locations in North Carolina and Colorado also stopped giving doses due to reactions.

However, according to a statement from the North Carolina Department of Health and Human Services, the CDC has found no safety issues or cause for concern regarding the J&J doses. The Colorado Department of Public Health and Environment also said there was “nothing to worry about.”

“After reviewing each patient’s symptoms, analyzing other vaccinations from the same vaccine lot, and speaking with the CDC to confirm our results, we are confident that there is no cause for concern,” said Dr. Eric France, chief medical officer of the department’s officer, said in a statement.

The J&J vaccine was the third vaccine approved in the United States, after vaccines from Pfizer and Moderna. According to CDC data, the company shipped nearly 15 million cans in the US on Friday night.

The US delivers an average of 7 million vaccine doses per day over a seven-day period. One in five Americans is now fully vaccinated, according to the CDC.

The rate of new Covid cases and deaths in the US has fallen dramatically since the winter summit, when hundreds of thousands of new infections and thousands of deaths were reported daily.

According to the Johns Hopkins University, the 7-day average of new cases in the US was 67,000 on Saturday. This is comparable to the upswing that hit the nation last summer. The US reports an average of 982 deaths daily.

New infections are increasing in 23 states as the more infectious variant first identified in Great Britain has become the dominant strain. US President Joe Biden has urged states to grant vaccine appointments to all adults by April 19 as the nation struggles to immunize as many people as possible, people as good as the virus mutates.

Categories
Health

WHO warns of uptick in Covid instances globally after weeks of decline

WHO warns of uptick in Covid cases globally after weeks of decline

Medical workers move a patient to the intensive care unit of Sotiria Hospital as part of the coronavirus disease (COVID-19) pandemic on March 1, 2021 in Athens, Greece.

Giorgos Moutafis | Reuters

World Health Organization officials said Wednesday that scientists are trying to understand why Covid-19 cases are suddenly popping up in much of the world after weeks of infection.

2.6 million new cases were reported worldwide last week, up 7% from the previous week, the WHO said in its weekly epidemiological update, which reflects data received on Sunday morning. That follows six consecutive weeks of declining new cases around the world.

The reversal could be caused by the emergence of several new, more contagious variants of the coronavirus, easing public policies and what is known as pandemic fatigue, where people are tired of taking precautionary measures, the WHO said in its weekly report. Maria Van Kerkhove, WHO director of emerging diseases and zoonosis, said Wednesday during a question and answer session at the organization’s headquarters in Geneva that the global health agency is trying to better understand what is reversing the trend in each region and each Land caused.

“I can tell you that we are concerned about the introduction of vaccines and vaccinations in a number of countries. We still need people to do their actions on an individual level,” she said, urging people to exercise physical distancing practice and continue wearing masks when they are around others.

“Given this week-long increase in trends, it’s a pretty stern warning to all of us that we need to stay on course,” said Van Kerkhove. “We must continue to adhere to these measures.”

Dr. Mike Ryan, executive director of the WHO’s health emergencies program, suggested the increase could be because “we may relax a little before we get the full effect of vaccination”. He added that he understood the temptation to socialize and return to more normal behavior, but “the problem is every time we did that before the virus took advantage of it.”

Ryan reiterated that the cause of the surge in the cases remains unclear, but added that the tried and tested public health measures highlighted during the pandemic are still in effect.

“When the cases are decreasing it’s never all we do and when they are increasing it’s never all our fault,” he said.

Ryan noted that deaths have not yet risen with the cases, but that could change in the coming weeks. Hopefully, vaccinating those most severely affected by the disease could prevent an increase in deaths.

While the introduction of vaccines in some countries gives cause for optimism, Ryan noted that many nations around the world have not yet received doses. He said 80% of the doses were given in just 10 countries.

WHO’s remarks are consistent with those recently made by federal officials in the United States. Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, has been warning for days that the decline in new cases every day in the United States has stalled and increased.

In the past seven days, the United States reported an average of more than 65,400 new cases a day, according to Johns Hopkins University. That’s well below the high of about 250,000 new cases per day the country reported in early January, but it’s still well above the infection rate the US saw the summer when the virus swept the sun belt.

“At this level of cases where variants spread, we will completely lose the hard-earned ground we won,” Walensky said on Monday. “With these statistics, I’m really concerned that more states are rolling back the exact public health measures we have recommended to protect people from Covid-19.”

“Please listen to me clearly: at this level of cases with spreading variant, we are going to completely lose the hard-earned ground we have gained,” she said.

Categories
Business

CDC director warns decline in Covid circumstances could have stalled as variants unfold

Government does not know how much Covid vaccine the U.S. has

Dr. Rochelle Walensky, selected as director of the Centers for Disease Control and Prevention, speaks during an event at the Queen Theater in Wilmington, Del., Tuesday, December 8, 2020.

Susan Walsh | AP

The decline in Covid-19 cases reported in the US since early January could level off, a worrying shift as highly communicable variants pose a risk of exacerbation of infections, the head of the US Centers for Disease Control and Prevention said on Friday.

“In the past few weeks, cases and hospital admissions in the US have decreased since early January, and deaths have decreased over the past week,” said CDC director Dr. Rochelle Walensky during a press conference. “However, the latest data suggests that these declines may stall and possibly weaken if a number is still very high.”

According to a CNBC analysis of data compiled by Johns Hopkins University, the nation reports a daily average of around 73,376 new cases for the past week, a slight increase compared to a week ago. The US hit a high of nearly 250,000 cases per day in early January after the winter break.

The recent postponement could be a sign that new, highly transmittable variants of the coronavirus are starting to take hold, Walensky said. A variant, known as B.1.1.7 and first found in the UK, is expected to be the predominant variety in mid to late March, experts have predicted.

The B.1.1.7 variant appears to be causing about 10% of new Covid-19 cases in the US, up from just 1% a few weeks ago, Walensky said. However, some states have more cases of the highly communicable variant than others.

Senior U.S. health officials have warned in recent weeks that the variants could reverse the current downward trend in infections in the U.S. and delay the nation’s recovery from the pandemic.

The head of the federal health department said states shouldn’t start lifting restrictions on businesses and gatherings given the direction of the fall and the high prevalence of virus.

“I want to be clear: cases, hospital admissions and deaths are still very high, and the recent postponement of the pandemic must be taken extremely seriously,” said Walensky.

The Chief Medical Officer of the White House, Dr. Anthony Fauci said the nation will be in “a precarious position” if the number of new cases every day starts to surge to around 70,000.

“We need to carefully consider what happens to these numbers over the next few weeks before you see the understandable need to relax with certain restrictions,” said Fauci.